Fusen Pharmaceutical Company Limited (HKG:1652)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.130
-0.030 (-2.59%)
Apr 29, 2026, 3:57 PM HKT
343.14%
Market Cap 835.41M
Revenue (ttm) 304.20M
Net Income (ttm) -13.11M
Shares Out 739.30M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 85,000
Average Volume 334,200
Open 1.120
Previous Close 1.160
Day's Range 1.110 - 1.150
52-Week Range 0.235 - 1.750
Beta 0.27
RSI 42.98
Earnings Date Mar 31, 2026

About HKG:1652

Fusen Pharmaceutical Company Limited, an investment holding company, researches and develops, manufactures, and sells pharmaceutical products in the People’s Republic of China. The company’s product portfolio includes Shuanghuanglian oral solutions and Shuanghuanglian injections; Sanhuang tablet; heat-clearing and detoxicating oral solutions; nicardipine hydrochloride injections; and other products. It also offers small and large volume injections, oral liquids, tablets, capsules, granules, traditional Chinese medicine extracts, and chemical sy... [Read more]

Sector Healthcare
Founded 2003
Employees 1,005
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1652
Full Company Profile

Financial Performance

In 2025, HKG:1652's revenue was 273.37 million, a decrease of -16.15% compared to the previous year's 326.03 million. Losses were -11.78 million, -93.76% less than in 2024.

Financial numbers in CNY Financial Statements

News

There is no news available yet.